Best part According to EO 121, an EUA for a COVID
Post# of 148158
According to EO 121, an EUA for a COVID-19 drug or vaccine shall only be issued when all three circumstances are present:
• It is reasonable to believe that the drug or vaccine may be effective to prevent, diagnose or treat COVID-19;
• The known and potential benefits of the drug or vaccine when used to diagnose, prevent or treat COVID-19 outweigh the known and potential risks of the drug or vaccine if any; and
• There is no adequate, approved and available alternative to the drug or vaccine for diagnosing, preventing or treating COVID-19.
The filing of application for EUA issuance shall be done by the industry or government concerned, “such as the national procurer or the public health program implementer,” the EO read.